Voss Capital, LLC Cognition Therapeutics Inc Transaction History

Voss Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$1.56 - $3.38 $155,611 - $337,158	-99,751 Reduced 62.35%	60,222 $110,000
Q1 2023 May 12, 2023	SELL	$1.51 - $2.3 $10,464 - $15,938	-6,930 Reduced 4.15%	159,973 $316,000
Q4 2022 Feb 13, 2023	SELL	$1.17 - $3.51 $61,070 - $183,211	-52,197 Reduced 23.82%	166,903 $350,000
Q3 2022 Nov 02, 2022	SELL	$1.63 - $3.6 $147,306 - $325,339	-90,372 Reduced 29.2%	219,100 $416,000
Q2 2022 Aug 09, 2022	BUY	$1.5 - $3.45 $424,549 - $976,463	283,033 Added 1070.51%	309,472 $653,000
Q4 2021 Feb 14, 2022	BUY	$5.1 - $12.98 $134,838 - $343,178	26,439 New	26,439 $167,000

6.58M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $13.2M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Voss Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Voss Capital, LLC with notifications on news.